secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0000105770-24-000035
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West CFO Bernard Birkett transitions to sole CFO; operating duties decentralized
--------------------------------------------------------------------------------

- CFO Bernard Birkett's role narrowed from CFO & COO to solely CFO effective May 1, 2024; operating leadership moves to business segments.
- Shareholders elected 11 directors, approved say-on-pay (96.1% for), and ratified PricewaterhouseCoopers as auditor.
- Charter amendments eliminating supermajority requirements for transactions and amendments approved with over 99% support.
- A shareholder proposal on redundant topics was not presented after SEC no-action letter in West's favor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000035/0000105770-24-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000035/wst-20240423.htm
  HTML page:      https://secwatch.observer/filing/0000105770-24-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer